DT-168

DT-168 · Design Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DT-168, covering 2025-12-29 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy [Phase 2]